Brookstone Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.49M | Buy |
3,840
+620
| +19% | +$230K | 0.01% | 583 |
|
|
2026
Q1 | $943K | Buy |
3,220
+476
| +17% | +$156K | 0.01% | 665 |
|
|
2025
Q4 | $962K | Buy |
2,744
+704
| +35% | +$238K | 0.01% | 639 |
|
|
2025
Q3 | $659K | Sell |
2,040
-8,259
| -80% | -$2.57M | 0.01% | 736 |
|
|
2025
Q2 | $4.01M | Buy |
10,299
+506
| +5% | +$204K | 0.05% | 316 |
|
|
2025
Q1 | $4.26M | Buy |
9,793
+8,563
| +696% | +$3.44M | 0.06% | 282 |
|
|
2024
Q4 | $454K | Sell |
1,230
-169
| -12% | -$70.7K | 0.01% | 718 |
|
|
2024
Q3 | $728K | Buy |
1,399
+97
| +7% | +$51.8K | 0.01% | 596 |
|
|
2024
Q2 | $678K | Sell |
1,302
-54
| -4% | -$28.5K | 0.01% | 577 |
|
|
2024
Q1 | $703K | Sell |
1,356
-252
| -16% | -$125K | 0.01% | 554 |
|
|
2023
Q4 | $758K | Buy |
1,608
+102
| +7% | +$47.2K | 0.01% | 512 |
|
|
2023
Q3 | $698K | Buy |
1,506
+146
| +11% | +$66.2K | 0.02% | 503 |
|
|
2023
Q2 | $584K | Sell |
1,360
-39
| -3% | -$18K | 0.01% | 538 |
|
|
2023
Q1 | $678K | Sell |
1,399
-122
| -8% | -$58.1K | 0.01% | 529 |
|
|
2022
Q4 | $723K | Sell |
1,521
-140
| -8% | -$71.1K | 0.01% | 500 |
|
|
2022
Q3 | $773K | Sell |
1,661
-598
| -26% | -$286K | 0.02% | 456 |
|
|
2022
Q2 | $1.09M | Sell |
2,259
-933
| -29% | -$462K | 0.02% | 386 |
|
|
2022
Q1 | $1.63M | Sell |
3,192
-144
| -4% | -$65.8K | 0.03% | 310 |
|
|
2021
Q4 | $1.45M | Sell |
3,336
-247
| -7% | -$104K | 0.03% | 315 |
|
|
2021
Q3 | $1.34M | Sell |
3,583
-776
| -18% | -$295K | 0.02% | 330 |
|
|
2021
Q2 | $1.74M | Buy |
4,359
+1,423
| +48% | +$544K | 0.03% | 278 |
|
|
2021
Q1 | $1.05M | Buy |
2,936
+672
| +30% | +$216K | 0.04% | 247 |
|
|
2020
Q4 | $727K | Sell |
2,264
-2
| -0.1% | -$614 | 0.03% | 280 |
|
|
2020
Q3 | $609K | Buy |
2,266
+38
| +2% | +$10.2K | 0.03% | 247 |
|
|
2020
Q2 | $586K | Buy |
2,228
+499
| +29% | +$133K | 0.04% | 218 |
|
|
2020
Q1 | $393K | Sell |
1,729
-100
| -5% | -$27.3K | 0.02% | 234 |
|
|
2019
Q4 | $552K | Buy |
1,829
+144
| +9% | +$39.6K | 0.03% | 265 |
|
|
2019
Q3 | $405K | Buy |
1,685
+79
| +5% | +$21.6K | 0.02% | 299 |
|
|
2019
Q2 | $453K | Buy |
1,606
+565
| +54% | +$154K | 0.03% | 291 |
|
|
2019
Q1 | $299K | Buy |
1,041
+117
| +13% | +$33.8K | 0.02% | 330 |
|
|
2018
Q4 | $243K | Sell |
924
-165
| -15% | -$45.4K | 0.02% | 257 |
|
|
2018
Q3 | $299K | Sell |
1,089
-300
| -22% | -$77.9K | 0.02% | 334 |
|
|
2018
Q2 | $331K | Buy |
1,389
+54
| +4% | +$12.5K | 0.03% | 286 |
|
|
2018
Q1 | $293K | Buy |
+1,335
| New | +$314K | 0.03% | 272 |
|
|
2015
Q4 | – | Sell |
-280
| Closed | -$39K | – | 358 |
|
|
2015
Q3 | $39K | Hold |
280
| – | – | 0.01% | 492 |
|
|
2015
Q2 | $46K | Buy |
+280
| New | +$44.7K | 0.01% | 515 |
|
Other funds holding ELV
Brookstone Capital Management's ELV Position: Q2 2026 in Review
Brookstone Capital Management increased its Elevance Health (ELV) stake by 19% in Q2 2026, buying an estimated $230K and bringing the position to 3,840 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #583.
Brookstone Capital Management first reported a position in ELV in Q2 2015 and has held it in 36 quarters since. The position peaked at $4.26M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Brookstone Capital Management held 3,840 shares of Elevance Health worth $1.49M as of Q2 2026.
- Brookstone Capital Management bought 620 Elevance Health shares in Q2 2026, an estimated $230K.
- Elevance Health made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #583 holding.
- Brookstone Capital Management first reported a position in Elevance Health in Q2 2015 and has held it in 36 quarters since.
- Brookstone Capital Management's Elevance Health position peaked at $4.26M in Q1 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.